Lv5
1230 积分 2025-03-26 加入
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
10天前
已完结
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
10天前
已完结
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
10天前
已完结
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors
10天前
已完结
ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas
10天前
已完结
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
10天前
已完结
Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial
10天前
已完结
Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
23天前
已完结
Dual-radiomics based on SHapley additive explanations for predicting hematologic toxicity in concurrent chemoradiotherapy patients
23天前
已完结
Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study
23天前
已完结
皖公网安备34019202002308
